{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:57Z","timestamp":1761606777675,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000900","name":"European Commission Joint Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000900","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jchromb.2021.122893","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T03:37:10Z","timestamp":1628393830000},"page":"122893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Determination of in vitro metabolic hepatic clearance of valproic acid (VPA) and five analogues by UPLC-MS-QTOF, applicable in alternatives to animal testing"],"prefix":"10.1016","volume":"1181","author":[{"given":"Salvador","family":"Fortaner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Mendoza-De Gyves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Maria","family":"Lostia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2021.122893_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0021-9258(18)43181-X","article-title":"Fatty acid metabolism. The mechanism of ketone body synthesis from fatty acids, with isotopic carbon as tracer","volume":"155","author":"Weinhouse","year":"1944","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jchromb.2021.122893_b0010","doi-asserted-by":"crossref","unstructured":"J. Bessems, S. Coecke, V. Gouliarmou, M. Whelan, A. Worth, EURL ECVAM strategy for achieving 3Rs impact in the assessment of toxicokinetics and systemic toxicity (2015).","DOI":"10.1016\/j.toxlet.2015.08.372"},{"key":"10.1016\/j.jchromb.2021.122893_b0015","unstructured":"Regulation (EC) No 1907\/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)."},{"issue":"12","key":"10.1016\/j.jchromb.2021.122893_b0045","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1289\/ehp.1409342","article-title":"Chemical Safety Assessment Using Read-Across: Assessing the Use of Novel Testing Methods to Strengthen the Evidence Base for Decision Making","volume":"123","author":"Berggren","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jchromb.2021.122893_b0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tiv.2018.08.004","article-title":"Establishing a systematic framework to characterise in vitro methods for human hepatic metabolic clearance","volume":"53","author":"Gouliarmou","year":"2018","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.jchromb.2021.122893_b0055","unstructured":"ECHA. Read-across Assessment Framework (RAAF). ECHA-17-R-01-EN, Helsinki, Finland (2017). (ISBN: 978-92-9495-758-0)."},{"issue":"3","key":"10.1016\/j.jchromb.2021.122893_b0085","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.yrtph.2015.05.016","article-title":"A strategy for structuring and reporting a read-across prediction of toxicity","volume":"72","author":"Schultz","year":"2015","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.jchromb.2021.122893_b0090","unstructured":"Directive 2010\/63\/EU of the European Parliament and of the Council. Official Journal of the European Union. Retrieved 17 April 2016."},{"issue":"3","key":"10.1016\/j.jchromb.2021.122893_b0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.taap.2012.08.018","article-title":"Assessment of the role of in situ generated (E)-2,4-diene-valproic acid in the toxicity of valproic acid and (E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes","volume":"264","author":"Surendradoss","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.jchromb.2021.122893_b0100","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/03602530600959433","article-title":"Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity","volume":"38","author":"Chang","year":"2006","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.jchromb.2021.122893_bib101","series-title":"Towards the Replacement of in Vivo Repeated Dose Systemic Toxicity Testing","first-page":"47","article-title":"Scientific Expert Panel of the SEURAT-1 Research Initiative. SEURAT: vision, research strategy and execution","volume":"1","author":"Whelan","year":"2011"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221003743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023221003743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:06:12Z","timestamp":1761606372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023221003743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":11,"alternative-id":["S1570023221003743"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122893","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of in vitro metabolic hepatic clearance of valproic acid (VPA) and five analogues by UPLC-MS-QTOF, applicable in alternatives to animal testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2021.122893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122893"}}